Outcome after single dose of ChAdOx1 vaccine against SARS-CoV-2 infection at 16 weeks post-vaccination among healthy adults in Saudi Arabia

Outcome after single dose of ChAdOx1 vaccine against SARS-CoV-2 infection at 16 weeks post-vaccination among healthy adults in Saudi Arabia

BACKGROUND: The rate of severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) infection and immunogenicity of a single dose of ChAdOx1 vaccine at 16 weeks post-vaccination among young and healthy participants remains unclear in Saudi Arabia. OBJECTIVES: Assess the rate of subsequent infection...

Full description

Bibliographic Details
Main Authors: Ahlam Alghamdi, Nasser Alsanea, Mohammed Alraey, Mercy Joseph, Mohammed Aboud, Thamer Almangour, Wasaef Alharbi, Hind Alhumidan, Abdalrhman Alanizi, Ahmed Al-jedai
Format: Article
Language:English
Published: King Faisal Specialist Hospital and Research Centre 2022-07-01
Series:Annals of Saudi Medicine
Online Access:http://www.annsaudimed.net/doi/10.5144/0256-4947.2022.223

Internet

http://www.annsaudimed.net/doi/10.5144/0256-4947.2022.223

Similar Items